The Journal of Medical Microbiology, Vol 43, Issue 5 344-347, Copyright © 1995 by Society for General Microbiology

JOURNAL ARTICLE

Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis

R. A. Bowden, A. Cloeckaert, M. S. Zygmunt and G. Dubray
Laboratoire de Pathologie Infectieuse et Immunologie, Institut National de la Recherche Agronomique, Centre de Recherches de Tours, Nouzilly, France.

Brucella ovis, a naturally virulent rough Brucella species, is the aetiological agent of ram epididymitis. The identification of protective antigens is necessary to obtain a safe, specific subcellular vaccine. Monoclonal antibodies (MAbs) directed at both brucella outer-membrane proteins (OMPs) and rough lipopolysaccharide (R-LPS) in a mouse protection test were used to identify potential targets for humoral immunity. Mixtures of MAbs directed at the 16.5-, 25-27-, 31-34- and 36-38-kDa OMPs conferred significant protection 7 days after challenge with reference strain B. ovis 63/290 compared with controls receiving either saline or an anti-brucella O-polysaccharide MAb. Furthermore, an anti-R-LPS MAb tested alone conferred protection at a level comparable with that obtained with the mixture of anti-OMP MAbs. The combination of protective OMP MAbs with the anti-R-LPS MAb was also strongly protective. One combination of OMP MAbs, which bound intensely to B. ovis in vitro, was ineffective. These results indicate that B. ovis OMPs and R-LPS are targets for protective antibodies and that they can be regarded as candidates for ram epididymitis subcellular vaccines.

This article has been cited by other articles:

				J. Cassataro, C. A. Velikovsky, L. Bruno, S. M. Estein, S. de la Barrera, R. Bowden, C. A. Fossati, and G. H. Giambartolomei Improved Immunogenicity of a Vaccination Regimen Combining a DNA Vaccine Encoding Brucella melitensis Outer Membrane Protein 31 (Omp31) and Recombinant Omp31 Boosting Clin. Vaccine Immunol., July 1, 2007; 14(7): 869 - 874. [Abstract] [Full Text] [PDF]

				J. Cassataro, S. M. Estein, K. A. Pasquevich, C. A. Velikovsky, S. de la Barrera, R. Bowden, C. A. Fossati, and G. H. Giambartolomei Vaccination with the Recombinant Brucella Outer Membrane Protein 31 or a Derived 27-Amino-Acid Synthetic Peptide Elicits a CD4+ T Helper 1 Response That Protects against Brucella melitensis Infection Infect. Immun., December 1, 2005; 73(12): 8079 - 8088. [Abstract] [Full Text] [PDF]

				J. Cassataro, C. A. Velikovsky, S. de la Barrera, S. M. Estein, L. Bruno, R. Bowden, K. A. Pasquevich, C. A. Fossati, and G. H. Giambartolomei A DNA Vaccine Coding for the Brucella Outer Membrane Protein 31 Confers Protection against B. melitensis and B. ovis Infection by Eliciting a Specific Cytotoxic Response Infect. Immun., October 1, 2005; 73(10): 6537 - 6546. [Abstract] [Full Text] [PDF]

				C. A. Velikovsky, F. A. Goldbaum, J. Cassataro, S. Estein, R. A. Bowden, L. Bruno, C. A. Fossati, and G. H. Giambartolomei Brucella Lumazine Synthase Elicits a Mixed Th1-Th2 Immune Response and Reduces Infection in Mice Challenged with Brucella abortus 544 Independently of the Adjuvant Formulation Used Infect. Immun., October 1, 2003; 71(10): 5750 - 5755. [Abstract] [Full Text] [PDF]

				D. Monreal, M. J. Grillo, D. Gonzalez, C. M. Marin, M. J. De Miguel, I. Lopez-Goni, J. M. Blasco, A Cloeckaert, and I. Moriyon Characterization of Brucella abortus O-Polysaccharide and Core Lipopolysaccharide Mutants and Demonstration that a Complete Core Is Required for Rough Vaccines To Be Efficient against Brucella abortus and Brucella ovis in the Mouse Model Infect. Immun., June 1, 2003; 71(6): 3261 - 3271. [Abstract] [Full Text] [PDF]

				C. A. Velikovsky, J. Cassataro, G. H. Giambartolomei, F. A. Goldbaum, S. Estein, R. A. Bowden, L. Bruno, C. A. Fossati, and M. Spitz A DNA Vaccine Encoding Lumazine Synthase from Brucella abortus Induces Protective Immunity in BALB/c Mice Infect. Immun., May 1, 2002; 70(5): 2507 - 2511. [Abstract] [Full Text] [PDF]

				N. Vizcaino, R. Kittelberger, A. Cloeckaert, C. M. Marin, and L. Fernandez-Lago Minor Nucleotide Substitutions in the omp31 Gene of Brucella ovis Result in Antigenic Differences in the Major Outer Membrane Protein That It Encodes Compared to Those of the Other Brucella Species Infect. Immun., November 1, 2001; 69(11): 7020 - 7028. [Abstract] [Full Text] [PDF]

				C. M. Fernandez-Prada, M. Nikolich, R. Vemulapalli, N. Sriranganathan, S. M. Boyle, G. G. Schurig, T. L. Hadfield, and D. L. Hoover Deletion of wboA Enhances Activation of the Lectin Pathway of Complement in Brucella abortus and Brucella melitensis Infect. Immun., July 1, 2001; 69(7): 4407 - 4416. [Abstract] [Full Text] [PDF]

				G. RAPONI, M. C. GHEZZI, M. T. LUN, G. BIGOTTI, P. G. NATALI, and C. MANCINI Protective features of monoclonal antibodies to Escherichia coli during experimental infection of mice with homologous and heterologous serotypes of E. coli J. Med. Microbiol., March 1, 2000; 49(3): 253 - 260. [Abstract] [Full Text] [PDF]